Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 48OTHER 46OTHER_GOV 3UNKNOWN 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 196Neoplasms 104Colorectal Neoplasms 91Stomach Neoplasms 80Uterine Cervical Neoplasms 70Carcinoma, Non-Small-Cell Lung 67Carcinoma, Hepatocellular 53Lung Neoplasms 48Prostatic Neoplasms 47Rectal Neoplasms 46Esophageal Neoplasms 39Pancreatic Neoplasms 37Colonic Neoplasms 36Ovarian Neoplasms 35Recurrence 33Head and Neck Neoplasms 33Neoplasm Metastasis 28Motor Activity 28Multiple Myeloma 27Small Cell Lung Carcinoma 26Melanoma 25Polycystic Ovary Syndrome 24Lymphoma, Non-Hodgkin 24Lymphoma 24Leukemia, Myeloid, Acute 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Pain 20Brain Neoplasms 20Nasopharyngeal Carcinoma 18Hematologic Neoplasms 17

Interventions

toripalimab 1Vinorelbine 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Advanced Breast Cancer × Clear all
NCT07540533 2026-04-20

2025-370

Henan Cancer Hospital

Phase 2 Recruiting
92 enrolled
Breast

Advanced Breast Cancer

NCT07125950 2025-08-15

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Henan Cancer Hospital

Phase 2 Not yet recruiting
60 enrolled
Breast

Advanced Breast Cancer

NCT06176534 2024-08-20

Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase â…¡ Clinical Trial

Henan Cancer Hospital

Phase 2 Recruiting
240 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡